NCT02178501View on ClinicalTrials.gov

Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.

NACompletedINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions

Type 2 DiabetesCardiovascular Diseases

Interventions

DIETARY_SUPPLEMENT

Omega-3 PUFA

comparison of omega-3 PUFA supplementation 2000 mg once daily (1000 mg EPA and 1000 mg DHA) versus placebo

Trial Locations (2)

40-635

Samodzielny Publiczny Szpital Kliniczny nr 7 Śląskiego Uniwersytetu Medycznego w Katowicach Górnośląskie Centrum Medyczne im. prof. Leszka Gieca, Katowice

31-202

Krakowski Szpital Specjalistyczny im. Jana Pawła II, Krakow

All Listed Sponsors

collaborator

National Science Centre, Poland

OTHER_GOV

lead

Jagiellonian University

OTHER

NCT02178501 - Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease. | Biotech Hunter | Biotech Hunter